Skip to content

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Selenium nanoparticles for breast cancer: mechanisms, delivery strategies, and translational challenges

It is highlighted that future progress will depend on standardized formulations, rigorous in vivo validation, and biomarker-informed clinical development rather than unselected selenium use, with particular emphasis on selenium nanoparticles (SeNPs) as engineerable platforms for breast cancer therapy.

Hui-Jia Ni, Xu Fu, Xiaoyu Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.